Project measures / variables set:   Gershenfeld1   TST_Rx

ID, description, units MPD:16203   TST_Rx   TST duration of immobility, treatment group, 6 min test   [s]  
imipramine study
Measures • baseline    • imipramine 30mg/kg
Data set, strains Gershenfeld1   inbred   12 strains     sex: m     age: 5-10wks
Procedure tail suspension test
Comparisonrepeated measures, baseline then treated, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Gershenfeld1 - TST duration of immobility, treatment group, 6 min test





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
between   strain 11 94413.5908 8583.0537 6.8474 < 0.0001
between   Residuals 50 62673.8286 1253.4766
within   group 1 4227.2258 4227.2258 4.4637 0.0396
within   group:strain 11 22348.9742 2031.7249 2.1454 0.0336
within   Residuals 50 47350.8 947.016

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Gershenfeld1 16203 tail suspension test imipramine TST duration of immobility, treatment group, 6 min test   [s]   baseline  TST_preRx inbred 12 m 5-10wks
Gershenfeld1 16204 tail suspension test imipramine TST duration of immobility, treatment group, 6 min test   [s]   imipramine 30mg/kg  TST_postRx inbred 12 m 5-10wks